Red Cedar Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.7M | Buy |
186,501
+306
| +0.2% | +$2.79K | 1.08% | 24 |
|
|
2022
Q3 | $1.5M | Sell |
186,195
-8
| -0% | -$65 | 1.04% | 28 |
|
|
2022
Q2 | $1.4M | Buy |
186,203
+164
| +0.1% | +$1.23K | 0.95% | 30 |
|
|
2022
Q1 | $1.75M | Buy |
186,039
+119
| +0.1% | +$1.12K | 1.05% | 26 |
|
|
2021
Q4 | $1.49M | Buy |
185,920
+1,250
| +0.7% | +$10K | 0.85% | 31 |
|
|
2021
Q3 | $1.8M | Buy |
184,670
+2,068
| +1% | +$20.1K | 1.1% | 25 |
|
|
2021
Q2 | $1.81M | Sell |
182,602
-527
| -0.3% | -$5.22K | 1.14% | 24 |
|
|
2021
Q1 | $2.11M | Buy |
183,129
+1,821
| +1% | +$21K | 1.41% | 21 |
|
|
2020
Q4 | $1.75M | Buy |
181,308
+67,228
| +59% | +$649K | 1.28% | 23 |
|
|
2020
Q3 | $1.03M | Buy |
114,080
+536
| +0.5% | +$4.83K | 0.9% | 31 |
|
|
2020
Q2 | $1.4M | Sell |
113,544
-1,629
| -1% | -$20.1K | 1.27% | 24 |
|
|
2020
Q1 | $1.03M | Buy |
115,173
+68,176
| +145% | +$612K | 1.04% | 28 |
|
|
2019
Q4 | $461K | Buy |
46,997
+584
| +1% | +$5.73K | 0.35% | 48 |
|
|
2019
Q3 | $319K | Hold |
46,413
| – | – | 0.26% | 50 |
|
|
2019
Q2 | $428K | Sell |
46,413
-254
| -0.5% | -$2.34K | 0.36% | 43 |
|
|
2019
Q1 | $732K | Buy |
46,667
+380
| +0.8% | +$5.96K | 0.62% | 34 |
|
|
2018
Q4 | $714K | Buy |
46,287
+40,436
| +691% | +$624K | 0.69% | 31 |
|
|
2018
Q3 | $126K | Hold |
5,851
| – | – | 0.11% | 69 |
|
|
2018
Q2 | $142K | Hold |
5,851
| – | – | 0.13% | 68 |
|
|
2018
Q1 | $99K | Hold |
5,851
| – | – | 0.09% | 73 |
|
|
2017
Q4 | $111K | Buy |
+5,851
| New | +$111K | 0.09% | 71 |
|